Deka Bank Deutsche Girozentrale Cytokinetics Inc Transaction History
Deka Bank Deutsche Girozentrale
- $54.1 Billion
- Q4 2024
A detailed history of Deka Bank Deutsche Girozentrale transactions in Cytokinetics Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 57,500 shares of CYTK stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,500
Previous 57,500
-0.0%
Holding current value
$2.46 Million
Previous $2.98 Million
10.18%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CYTK
# of Institutions
407Shares Held
125MCall Options Held
4.6MPut Options Held
2.42M-
Black Rock Inc. New York, NY14.7MShares$627 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$503 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$414 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$332 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$276 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.03B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...